Cargando…

PReS-FINAL-2074: The role of the probiotic VSL-3 as adjuvant therapy in patients with undifferentiated spondyloarthritis (ERA)

Detalles Bibliográficos
Autores principales:	Vidovic, M, Perica, M, Lamot, L, Zaninovic, M, Tambic Bukovac, L, Harjacek, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044149/ http://dx.doi.org/10.1186/1546-0096-11-S2-P86

Ejemplares similares

PReS-FINAL-2073: The usefulness of musculoskeletal ultrasound in monitoring efficacy of intraarticular infliximab therapy in JIA patients
por: Vidovic, M, et al.
Publicado: (2013)

PReS-FINAL-2151: HLA B27/B7, TLR-4, NLRP3, CXCR4 AND PTPN12: the shared genetic master-key genes leading to development of undifferentiated spondyloarthritis/era in children
por: Lamot, L, et al.
Publicado: (2013)

PReS-FINAL-2078: Single nucleotide polymorphisms of toll like receptors 2 and 4 in enthesitis related arthritis and oligo and polyarticular juvenile idiopathic arthritis
por: Perica, M, et al.
Publicado: (2013)

Potential biomarkers and therapeutic targets in juvenile spondyloarthritis patients
por: Lamot, Lovro, et al.
Publicado: (2014)

Single nucleotide polymorphism of NLRP3 (Q705K) In juvenile spondyloarthritis and oligo/ polyarticular juvenile idiopathic arthritis
por: Perica, Marija, et al.
Publicado: (2014)

Aberrant Expression of Shared Master-Key Genes Contributes to the Immunopathogenesis in Patients with Juvenile Spondyloarthritis
por: Lamot, Lovro, et al.
Publicado: (2014)

Monitoring the efficacy of intraarticular infliximab by musculoskeletal ultrasound and juvenile arthritis disease acitivty score (JADAS) in JIA patients – single center experience
por: Vidovic, Mandica, et al.
Publicado: (2014)

Virtual 3D/4D vascular sonobiopsy of the knee joint: validation of the method in the JIA patients treated with ia infliximab or triamcinolone hexacetonide
por: Harjacek, Miroslav, et al.
Publicado: (2014)

The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Harjacek, Miroslav, et al.
Publicado: (2018)

Unusual localization and presentation of osteoid osteoma mimicking juvenile spondyloarthritis: a case report
por: Vlaic, Josip, et al.
Publicado: (2019)

Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA
por: Ilhan, O., et al.
Publicado: (2022)

Clavicular cortical hyperostosis: new autoinflammatory entity or part of the juvenile spondyloarthropathies clinical picture?
por: Lamot, L, et al.
Publicado: (2011)

Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2022)

Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

PReS-FINAL-2209: MEFV gene mutations in central and south-eastern European countries
por: Perko, D, et al.
Publicado: (2013)

Retrospective study of juvenile systemic lupus erythematosus (JSLE) over the last 20 years: single center experience
por: Tambic Bukovac, L, et al.
Publicado: (2008)

Secteur 30 LEAR (Dessin no. E00-2074-0)
por: Bourquin, P
Publicado: (1988)

Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
por: Cheng, Fang-Shu, et al.
Publicado: (2020)

The therapeutic value of low-energy laser (LLLT) for enthesitis in children with juvenile spondyloarthropathies
por: Harjacek, M, et al.
Publicado: (2008)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

PReS-FINAL-1010: circulating micrornas in traps
por: Lucherini, OM, et al.
Publicado: (2013)

Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”
por: Sang, Li-Xuan
Publicado: (2021)

Probiotic colonization dynamics after oral consumption of VSL#3(®) by antibiotic-treated mice
por: Theriot, Casey, et al.
Publicado: (2022)

Idiopathic hypereosinophilic syndrome (HES) in a 15 year-old girl
por: Jelusic, M, et al.
Publicado: (2008)

Beyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndrome
por: Vukić, Vana, et al.
Publicado: (2021)

The Increased Levels of Fecal Calprotectin in Children With Active Enthesitis Related Arthritis and MRI Signs of Sacroiliitis: The Results of a Single Center Cross-Sectional Exploratory Study in Juvenile Idiopathic Arthritis Patients
por: Lamot, Lovro, et al.
Publicado: (2021)

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
por: Arthur, Janelle C., et al.
Publicado: (2013)

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
por: Boonma, Prapaporn, et al.
Publicado: (2021)

Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
por: Rashid, Sherzad K., et al.
Publicado: (2014)

PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

Undifferentiated spondyloarthritis following allogeneic stem cell transplantation
por: Karia, Vijay R, et al.
Publicado: (2010)

Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3
por: Mora, Diego, et al.
Publicado: (2019)

The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor
por: Dharmani, Poonam, et al.
Publicado: (2013)

Correction: Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
Publicado: (2014)

Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3
por: Vicari, Enzo, et al.
Publicado: (2014)

Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
por: Distrutti, Eleonora, et al.
Publicado: (2013)

Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation
por: Kim, Seong-Eun, et al.
Publicado: (2015)

The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Relationship of HS CRP and Sacroiliac Joint Inflammation in Undifferentiated Spondyloarthritis
por: Liu, Te-Jung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_efm6p3iebsefp0bevab015c559